Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Arizona Hispanics Poised To Swing State Blue

38 minutes ago
Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Edit note: This report contains accounts of rape, violence and other disturbing events.

Sex trafficking wasn't a major concern in the early 1980s, when Beth Jacobs was a teenager. If you were a prostitute, the thinking went, it was your choice.

Jacobs thought that too, right up until she came to on the lot of a dark truck stop one night. She says she had asked a friendly-seeming man for a ride home that afternoon.

Jacobs says he gave her something in an old McDonald's cup — a drug — and as she was waking up the man announced that he was a pimp. Her pimp.

The Boston Citgo sign, all 3,600 square LED feet of which has served as the backdrop to Red Sox games since 1965, is now officially a "pending landmark."

Spanish Surrealist Salvador Dalí spent much of the 1940s in the U.S., avoiding World War II and its aftermath. He was a well-known fixture on the art scene in Monterey, Calif. — and that's where the largest collection of Dalí's work on the West Coast is now open to the public.

Copyright 2016 Fresh Air. To see more, visit Fresh Air.

Pages

Novartis Loses Patent Battle In India

Apr 1, 2013
Originally published on April 5, 2013 8:50 am

Transcript

STEVE INSKEEP, HOST:

NPR's business news starts with a patent ruling that may affect millions.

(SOUNDBITE OF MUSIC)

INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.